The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...

While drugs can help manage symptoms, there is currently no cure for Lewy Body Dementia. Despite the challenges, Kent has ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

Early detection of Alzheimer’s disease has come a step closer thanks to a new measurement method developed by chemists at Utrecht University. Notorious protein clumps involved in dementias such ...

TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease. Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

Dr. Martínez-Lage shares Alzheimer's breakthroughs: why early diagnosis matters, the 4-step treatment plan for autonomy, and ...

Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of ...